CORONA DEL MAR, Calif.--(BUSINESS WIRE)--The Foundation to Eradicate Duchenne (FED), the CureDuchenne Foundation, AVI BioPharma and Prosensa will host an Exon Skipping Conference for Duchenne Muscular Dystrophy from October 14 -17, 2008 at the Banbury Center of Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. Participants are being drawn from a wide area of research, from chemistry to regulatory authorities, to critically review progress on oligonucleotides as therapeutic agents for Duchenne Muscular Dystrophy.
